Where was the author of the article 'Cascade Size Distributions: Why They Matter and How to Compute Them Efficiently' born?
Mountain Top, Pennsylvania
John Quackenbush is the alternative name for John Quackenbush. Kimberly Glass et al.: Sexually-dimorphic targeting of functionally related genes in COPD. (2014) authored by John Quackenbush. Markus S. Schröder et al.: RamiGO: an R/Bioconductor package providing an AmiGO Visualize interface. (2013) authored by John Quackenbush. John Quackenbush is the chief executive officer of Genospace which was acquired by Hospital Corporation of America (HCA) and merged with HCA's Sarah Cannon cancer institute as a wholly owned subsidiary. Quackenbush was awarded a four-million dollar fellowship by Australia's National Health and Medical Research Council to study chemotherapy resistant ovarian cancers in collaboration with colleagues at the University of Queensland's Institute for Molecular Biosciences.
[INST]
Utilize the provided context information, to generate answers to the following question: 
- Generate the answer to the question based on the provided context.
- Avoid including any explanations or apologies in your responses.
- Only respond to questions that ask for the answer to the target question without any additional information.
- Strictly provide the answer without any additional text.
Question: Where was the author of the article 'Cascade Size Distributions: Why They Matter and How to Compute Them Efficiently' born?
Context: John Quackenbush is the alternative name for John Quackenbush. Kimberly Glass et al.: Sexually-dimorphic targeting of functionally related genes in COPD. (2014) authored by John Quackenbush. Markus S. Schröder et al.: RamiGO: an R/Bioconductor package providing an AmiGO Visualize interface. (2013) authored by John Quackenbush. John Quackenbush is the chief executive officer of Genospace which was acquired by Hospital Corporation of America (HCA) and merged with HCA's Sarah Cannon cancer institute as a wholly owned subsidiary. Quackenbush was awarded a four-million dollar fellowship by Australia's National Health and Medical Research Council to study chemotherapy resistant ovarian cancers in collaboration with colleagues at the University of Queensland's Institute for Molecular Biosciences.
[/INST] Answer:
